Enhabit, Inc. (NYSE:EHAB) Receives $9.35 Average Price Target from Analysts

Shares of Enhabit, Inc. (NYSE:EHAB) have been given a consensus rating of “Reduce” by the seven brokerages that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating and six have issued a hold rating on the company. The average 1-year price objective among brokers that have covered the stock in the last year is $9.25.

Separately, Leerink Partners reaffirmed a “market perform” rating and issued a $8.00 target price (down previously from $8.50) on shares of Enhabit in a research report on Tuesday.

Enhabit Trading Down 0.6 %

Shares of EHAB opened at $7.41 on Tuesday. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. Enhabit has a 12-month low of $6.85 and a 12-month high of $11.74. The firm has a 50-day moving average price of $7.52 and a 200 day moving average price of $8.42. The firm has a market capitalization of $372.69 million, a P/E ratio of -3.19 and a beta of 1.84.

Enhabit (NYSE:EHAB) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The firm had revenue of $253.60 million during the quarter, compared to analysts’ expectations of $261.69 million. During the same period in the prior year, the company posted $0.03 EPS. Sell-side analysts forecast that Enhabit will post 0.25 EPS for the current year.

Institutional Trading of Enhabit

Hedge funds have recently made changes to their positions in the business. DekaBank Deutsche Girozentrale lifted its position in shares of Enhabit by 39.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 340,412 shares of the company’s stock worth $3,861,000 after purchasing an additional 95,488 shares in the last quarter. WINTON GROUP Ltd acquired a new stake in Enhabit in the second quarter valued at approximately $955,000. Marshall Wace LLP acquired a new stake in Enhabit in the second quarter valued at approximately $1,941,000. Orion Portfolio Solutions LLC raised its holdings in Enhabit by 72.5% in the first quarter. Orion Portfolio Solutions LLC now owns 96,833 shares of the company’s stock valued at $1,128,000 after acquiring an additional 40,684 shares in the last quarter. Finally, AREX Capital Management LP raised its holdings in Enhabit by 2.5% in the second quarter. AREX Capital Management LP now owns 2,472,662 shares of the company’s stock valued at $22,056,000 after acquiring an additional 59,353 shares in the last quarter.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.